Gastroenterology

The flagship journal of the @AmerGastroAssn, Gastroenterology is a premiere journal for original research in the field of GI disease. Impact Factor: 25.1

[Gastroenterology @AGA_Gastro]

Gastro has received a 2025 Impact Factor of 29.7! On behalf of Editors-in-Chief @PaulMoayyedi & David Weinberg, thank you to our editors, authors, reviewers & readers for your continued support. https://t.co/3iDWbj8NfM
#GITwitter #LiverTwitter
@AmerGastroAssn

[Gastroenterology @AGA_Gastro]

🧬 A DNA/RNA test on bile duct samples detects cancer more accurately than standard methods, especially in high-risk patients, and identifies gene changes that can guide personalized treatment.
🔗 https://t.co/9zYgoWv07d

[Gastroenterology @AGA_Gastro]

Study identifies a druggable biomarker that improves the prediction of endoscopic #CrohnsDisease recurrence, potentially guiding patient management and therapy in the future. Click the link to read more: 🔗 https://t.co/LPOYDauTFg

[Gastroenterology @AGA_Gastro]

🌟 153 gluten and placebo challenges from 1000mg to 1mg were given to people with #CeliacDisease. Study found that an eliciting dose did not result in an immune response in 95% (ED5) of participants.
🔗 Read more at https://t.co/rS8p1TfkO1

[Gastroenterology @AGA_Gastro]

🧬 Review highlights how polygenic risk scores and key variants such as PNPLA3, TM6SF2, and HSD17B13 may improve risk stratification for fibrosis progression and cirrhosis in #MASLD and #ALD.
🔗 https://t.co/JJh5I5f1cY

[Gastroenterology @AGA_Gastro]

💡 Study finds f-Hb–guided surveillance after polypectomy optimizes colonoscopy use, lowers #CRC risk, and outperforms USMSTF and ESGE guidelines in FIT-based screening. Learn more at https://t.co/ngj9kMle9I

[Sociedad Española de Patología Digestiva (SEPD) @sepdigestiva]

Todo 🫵 lo que necesitas saber 🤓 sobre la 🩺🩻 evaluación y el manejo 🩼💊💉 de la EII hospitalizada, según la
@AmerGastroAssn
@AGA_Gastro
✅ Colitis aguda grave
✅ Obstrucción del intestino delgado
✅ Absceso intraabdominal
✅ Enfermedad perianal
‼️🚨 La profilaxis de la trombosis venosa profunda (TVP) es fundamental 🚨‼️

🔗 https://t.co/pRlv7gtx7m

[Healio Gastroenterology @HealioGastro]

📍 Researchers developed #LiverFibrosis screening criteria that pinpoint individuals at the highest risk for #LiverDisease, per a study in @AGA_Gastro.

Screening-eligible adults had higher 10-year risks of:
❌ Incident #cirrhosis
❌ Liver-related death https://t.co/nXUTjhbroI

[Gastroenterology @AGA_Gastro]

📣 The August issue of Gastroenterology is now online! Essential reading includes:
🔹 An assessment of gluten threshold in #CeliacDisease
🔹 A study on intestinal ultrasound and severe pediatric IBD
🔹 Research on GI bleeding and cardiovascular outcomes
🔗 https://t.co/7B1j0Sf3sz

[Gastroenterology @AGA_Gastro]

Study finds that STING-deficient CAR-T cells + diABZI boost antitumor activity, increase CAR-T persistence, and improve tumor control in pancreatic cancer models. Click the link to read more:
🔗 https://t.co/ysCSmWaELk
@v_hornung @i_piseddu @hornung_lab

[Gastroenterology @AGA_Gastro]

💡Recordings of motion-guided biofeedback using abdominothoracic wall reduced rumination, providing the first simple, mechanism-based behavioral therapy directly translated from rumination physiology.
👉 Learn more at https://t.co/tLoFsxmwaC

[Gastroenterology @AGA_Gastro]

👶 Early life stress disrupts the gut-brain axis; reshapes enteric circuits, motility, and visceral pain via sex hormones and sympathetics, and link these mechanisms to #DGBI risk in human cohorts.
🔗 https://t.co/2IeEqAl5M7

[Gastroenterology @AGA_Gastro]

Nationwide cohort of 16,000 Swedish patients with isolated ulcerative proctitis showed no increased risk of rectal cancer or high-grade dysplasia compared with the general population over the course of 10 years.
🔗 https://t.co/TroRODvaGe
#UlcerativeProctitis #ColorectalCancer

[Gastroenterology @AGA_Gastro]

🩺 With #MASLD affecting nearly 1 in 3 U.S. adults, the AGA's updated Clinical Care Pathway incorporates the latest evidence on disease nomenclature, risk stratification, diagnosis, and treatment, including newly approved therapies.
🔗 https://t.co/ZA0mmjFcEq

[Gastroenterology @AGA_Gastro]

🧬 Commentary highlights how immunotherapy continues to transform care across metastatic, adjuvant, and neoadjuvant settings for patients with dMMR/MSI-H #colorectalcancer.
🔗 https://t.co/kzzHyZAJlP

[AASLD @AASLDtweets]

⏰One week left to provide feedback on the joint #AASLD @AGA_Gastro guideline for #PrimaryBiliaryCholangitis #PBC.

Your insights can help shape the final recommendations that guide clinical care. Review the draft guideline and submit your comments by Monday, July 13.

🔗Share your expertise: https://t.co/99vtZsFChX

[GI Nutrition Foundation @GI_NutritionFdn]

‼️Not all dietary fiber sources are the same for lowering #Crohnsdisease risk

💡@The_GEMProject followed up healthy people with high risk of Crohn's for 8.5 years and found ⬆️ ß-glucan and inulin intake were associated with:
🔸Preserved gut barrier function
🔸⬇️ inflammation
🔸⬇️ CD risk

When looking at 94 first-degree relatives (parents, siblings or children) who went on to develop the disease themselves from a pool of 3,314 individuals over a median of 8.5 years:

✅ ⬆️ beta-glucan (found in oats, barley, grains) and inulin (found in garlic, onions, leeks, asparagus) intake was protective of subsequent Crohn’s, each associated with around a 30% reduction in risk

✅ ⬆️ beta-glucan and inulin intakes were linked to:
🔸A ⬇️ in Ruminococcus torques, a species previously identified as the highest contributor to GEM Crohn’s disease microbiome risk

🔸⬇️ C-reactive protein (but not with changes in fecal calprotectin)

🔸⬇️ gut permeability

✅ ⬇️ intake of pectin, inulin, FOS, and beta-glucan was linked to impaired intestinal permeability and subclinical inflammation, while ⬇️ inulin intake was associated with ⬆️ fecal calprotectin levels

🌾🧅Don't underestimate the power of fermentable dietary fiber to reduce the risk of #Crohns among first-degree relatives of patients with the condition

@AGA_Gastro

📚Read more: https://t.co/PJbeULbrcS

🔍Editorial from @PaedsRH: https://t.co/OxTxSn0feJ

[Gastroenterology @AGA_Gastro]

While incidence has stabilized, prevalence continues to grow. An aging #IBD population will increasingly strain healthcare systems aiming to provide affordable, accessible, high-quality care.
🔗 https://t.co/DaVapG9c56

[Gastroenterology @AGA_Gastro]

Defecation urgency in #IBS reflects distinct gut–brain mechanisms. Real-life and barostat-induced urgency show different symptom profiles and brain correlates. Click the link to read more: https://t.co/hkxhp8CLmd

[Gastroenterology @AGA_Gastro]

Comparison of two #dose-intensification regimens in patients with #CrohnsDisease experiencing #LOR to #ustekinumab showed comparable low recapture of remission after 48 weeks.
🔗 https://t.co/kdX2Z86pC2

[Gastroenterology @AGA_Gastro]

Study finds ganglioside-mediated neural-acinar crosstalk facilitates pancreatic carcinogenesis via metaplastic niche remodeling. Read more at https://t.co/jBSGAfqA8W